Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net loss from continuing operations	$ (1,339,641)	$ (140,981)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,035,356	1,153
Amortization of debt discounts		29,338
Depreciation expense	1,412
Amortization of right-of-use asset	2,994
Impairment of fixed assets
Loss on settlement	(20,003)
Decrease (increase) in assets:
Other current assets	262,907	480
Increase (decrease) in liabilities:
Accounts payable	57,550	(24,082)
Accrued expenses	7,651	17,286
Accrued expenses – related parties	(7,500)	5,000
Lease liability	(8,678)
Net cash used in operating activities from continuing operations	(7,952)	(111,806)
Net cash provided by operating activities from discontinued operations		176,503
Net cash provided by operating activities	(7,952)	64,697
Cash flows from investing activities
Purchase of fixed assets	(1,731)
Net cash used in investing activities from continuing operations	(1,731)
Net cash used in investing activities from discontinued operations		(11,667)
Net cash used in investing activities	(1,731)	(11,667)
Cash flows from financing activities
Proceeds from notes payable	20,000
Proceeds from sale of Series C Preferred shares	100
Payment of deferred offering costs	(65,000)
Net cash used in financing activities from continuing operations	(44,900)
Net cash used in financing activities from discontinued operations		(15,784)
Net cash used in financing activities	(44,900)	(15,784)
Net increase (decrease) in cash	(54,583)	37,246
Cash – beginning	91,166	271,006
Cash – ending	36,583	308,252
Supplemental disclosures:
Interest paid		40,018
Income taxes paid
Non-cash investing and financing activities:
Accounts payable and accrued interest added to note principal balance		$ 30,965